About one in six people who take the most common medication for Parkinson’s disease will develop addictive behaviours. We found whether this happens depends on a person’s unique brain structure.
- Research Fellow, Systems Neuroscience Laboratory, QIMR Berghofer
Contact Philip for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Brisbane, Queensland
- Website
- X (formerly Twitter): @DrPhilipMosley
- Article Feed
- ORCID
- Joined
